A photo of Shabana Shahanavaz.

Director, Cardiac Catheterization Laboratory, The Heart Institute

Associate Professor, UC Department of Pediatrics

513-636-7072

Board Certified

"I have a passion for helping patients by being involved in multi-center trials and projects. These trials focus on developing interventional cardiology technology and a better understanding of available therapies to benefit patients around the world."

My Biography & Research

Biography

I’m a pediatric cardiologist specializing in congenital heart disease and interventional cardiology. I have a passion for helping patients by being involved in multi-center trials and projects. These trials focus on developing interventional cardiology technology and a better understanding of available therapies to benefit patients around the world.

I was inspired to become a pediatric cardiologist by members of my extended family, who were physicians. As director of the Cardiac Catheterization Laboratory at Cincinnati Children’s, I have clinical expertise in performing complex diagnostic and interventional cardiac catheterization instead of open-heart surgery or adjunct to surgical procedures.

When I worked in St. Louis, Missouri, I received the Best Doctor award in 2019 and 2020.

My research is focused on catheter-based intervention to treat congenital heart defects, clinical trials in congenital interventional catheterization, and innovations.

I enjoy spending my free time with my family.

Clinical Interests

Passion and clinical expertise in performing complex diagnostic and interventional cardiac catheterization in lieu of open heart surgery or as an adjunct to surgical procedures

Research Interests

Research focused on catheter-based intervention for treatment of congenital heart defects, clinical trials in congenital interventional catheterization, and innovations

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Clinical Divisions

Heart, Catheterization and Intervention

Research Divisions

Heart

My Locations

My Education

MBBS: Kasturba Medical College, Karnataka, India, 2002.

Residency: Pediatrics, Children's Hospital of Brooklyn, Brooklyn, NY, 2007.

Fellowship: Cardiology, University of California San Francisco, San Francisco, CA, 2010.

Fellowship: 4th year Advanced Fellowship in Interventional Cardiology, Morgan Stanley Children's Hospital, Manhattan, NY, 2011.

My Publications

Emerging solutions for the dilated native right ventricular outflow tract. Shahanavaz, S; Tang, J; Gillespie, MJ; Morgan, GJ. Progress in Pediatric Cardiology. 2021; 61.

Acute and mid-term outcomes of transcatheter pulmonary valve implantation in patients older than 40 years. Aldoss, O; Carr, K; Shahanavaz, S; Balzer, D; Levi, DS; Aboulhosn, J. International journal of cardiology congenital heart disease. 2021; 3.

Total Transcatheter Stage 1: A Word of Caution. Nageotte, S; Shahanavaz, S; Eghtesady, P; Balzer, D. Pediatric Cardiology. 2021.

Data quality methods through remote source data verification auditing: results from the Congenital Cardiac Research Collaborative. Pettus, JA; Pajk, AL; Glatz, AC; Petit, CJ; Goldstein, BH; Qureshi, AM; Nicholson, GT; Meadows, JJ; Zampi, JD; Law, MA; et al. Cardiology in the Young. 2021; 1-6.

Comparison of Management Strategies for Neonates With Symptomatic Tetralogy of Fallot. Goldstein, BH; Petit, CJ; Qureshi, AM; McCracken, CE; Kelleman, MS; Nicholson, GT; Law, MA; Meadows, JJ; Zampi, JD; Shahanavaz, S; et al. Journal of the American College of Cardiology. 2021; 77:1093-1106.

Midterm outcomes of the Potts shunt for pediatric pulmonary hypertension, with comparison to lung transplant. Lancaster, TS; Shahanavaz, S; Balzer, DT; Sweet, SC; Grady, RM; Eghtesady, P. Journal of Thoracic and Cardiovascular Surgery. 2021; 161:1139-1148.

Comparison of management strategies for neonates with symptomatic tetralogy of Fallot and weight <2.5 kg. Qureshi, AM; Caldarone, CA; Romano, JC; Chai, PJ; Mascio, CE; Glatz, AC; Petit, CJ; McCracken, CE; Kelleman, MS; Nicholson, GT; et al. Journal of Thoracic and Cardiovascular Surgery. 2021.

Transcatheter Pulmonary Valve Replacement With the Sapien Prosthesis. Shahanavaz, S; Zahn, EM; Levi, DS; Aboulhousn, JA; Hascoet, S; Qureshi, AM; Porras, D; Morgan, GJ; Bauser Heaton, H; Martin, MH; et al. Journal of the American College of Cardiology. 2020; 76:2847-2858.

Alterra Adaptive Prestent and SAPIEN 3 THV for Congenital Pulmonic Valve Dysfunction: An Early Feasibility Study. Shahanavaz, S; Balzer, D; Babaliaros, V; Kim, D; Dimas, V; Veeram Reddy, SR; Leipsic, J; Blanke, P; Shirali, G; Parthiban, A; et al. JACC: Cardiovascular Interventions. 2020; 13:2510-2524.

Amplatzer Piccolo Occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients ≥700 grams. Sathanandam, SK; Gutfinger, D; O'Brien, L; Forbes, TJ; Gillespie, MJ; Berman, DP; Armstrong, AK; Shahanavaz, S; Jones, TK; Morray, BH; et al. Catheterization and Cardiovascular Interventions. 2020; 96:1266-1276.